WAM
CVRS

Wakefield Asset Management’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History

Wakefield Asset Management’s Portfolio CVRS Stock Details CVRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-6,968
Closed -$21K – 213
2019
Q2 		$21K Hold
6,968
– – 0.01% 161
2019
Q1 		$12K Buy
+6,968
New +$9.63K ﹤0.01% 190

Other funds holding CVRS

HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
HEC
Hudson Executive Capital New York $151M AUM 60.14% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
SGCM
Sand Grove Capital Management London, United Kingdom $444M AUM 131.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Wakefield Asset Management's CVRS Position: Q3 2019 in Review

Wakefield Asset Management sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q3 2019, closing a stake of 6,968 shares — an estimated $21K sold.

Wakefield Asset Management first reported a position in CVRS in Q1 2019 and held it in 2 quarters. The position peaked at $21K in Q2 2019. 101 funds tracked by Wall St. Rank hold CVRS as of Q3 2019.

  • Wakefield Asset Management reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q3 2019 after selling out during the quarter.
  • Wakefield Asset Management sold 6,968 CORINDUS VASCULAR ROBOTICS, INC shares in Q3 2019, an estimated $21K.
  • Wakefield Asset Management first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q1 2019 and held it in 2 quarters.
  • Wakefield Asset Management's CORINDUS VASCULAR ROBOTICS, INC position peaked at $21K in Q2 2019.
  • 101 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q3 2019.

Based on Wakefield Asset Management's 13F filing for Q3 2019, filed 25 Oct 2019.